In 2015, the United Kingdom submitted a report to propose to amend Annex XVII of REACH to restrict placing on the market of D4 and D5 in personal care products. After 1st and 2nd public consultation, both of the Risk Assessment Committee (RAC) and the Socio-Economic Assessment Committee (SEAC) considered that the proposed restriction is the most appropriate EU wide measure to address the identified risks. And the ECHA submitted the final opinions to the European Commission (EC) in August 2016.